Clinical Trial Update: Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of pregabalin (Lyrica) in generalized anxiety disorder has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Generalized Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-04-19